Search

Displaying results 4231 - 4240 of 10000 in total
  1. Drug

    (4r)-2-Methylpentane-2,4-Diol

    go.drugbank.com/drugs/DB03564
    Experimental

    Synonyms: (4r)-2-Methylpentane-2,4-Diol
  2. Drug

    S,S-(2-Hydroxyethyl)Thiocysteine

    go.drugbank.com/drugs/DB04530
    Experimental

    Synonyms: S,S-(2-Hydroxyethyl)Thiocysteine
  3. Drug

    N(2)-succinyl-L-arginine

    go.drugbank.com/drugs/DB02501
    Experimental

    Synonyms: N(2)-succinyl-L-arginine, N2-Succinyl-L-arginine
  4. Drug

    2-(Oxalyl-Amino)-Benzoic Acid

    go.drugbank.com/drugs/DB02622
    Experimental

    Synonyms: 2-(Oxalyl-Amino)-Benzoic Acid
  5. Drug

    Testosterone enantate benzilic acid hydrazone

    go.drugbank.com/drugs/DB13947
    ApprovedWithdrawn

    Synonyms: Testosterone 17-enanthate 3-benzilic acid hydrazone
  6. Drug

    Narazaciclib

    go.drugbank.com/drugs/DB19038
    Investigational

    Narazaciclib is under investigation in clinical trial NCT06351644 (On 123300 (Narazaciclib) and Dexamethasone in Patients With Relapsed And/or Refractory Multiple Myeloma).

    Synonyms: Pyrido(2,3-d)pyrimidine-6-carbonitrile, 8-cyclopentyl-7,8-dihydro-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-7-oxo-
  7. Drug

    Cannabidiolic acid

    go.drugbank.com/drugs/DB19261
    Investigational

    Cannabidiolic acid is under investigation in clinical trial NCT04103814 (Effect of Topical CBD Cream for Degenerative Hallux Disorders).

    Synonyms: Benzoic acid, 2,4-dihydroxy-3-((1r,6r)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-6-pentyl-, 3-p-mentha-1,8-dien-3-yl-6-pentyl-beta-resorcylic acid
  8. Drug

    Binetrakin

    go.drugbank.com/drugs/DB12182
    Investigational

    Binetrakin has been used in trials studying the treatment of HIV Infections, Sarcoma, Kaposi, Non-Hodgkin's Lymphoma (NHL), Myelodysplastic Syndrome (MDS), and Leukemia, Acute Myelogenous (AML), among others.

    Synonyms: IL-4, Interleukin-4Categories: Interleukin-4, antagonists & inhibitors
  9. Drug

    Repotrectinib

    go.drugbank.com/drugs/DB16826
    ApprovedInvestigational

    This approval is based on favorable results from the TRIDENT-1 study, where the objective response rate was 79% in TKI-naive patients and 38% in TKI-pretreated patients respectively.[L48741] … Repotrectinib is a next-generation tyrosine kinase inhibitor (TKI) specifically designed to address resistance in the treatment of non-small cell lung cancer (NSCLC), specifically due to mutations in the

    Synonyms: (3R,6S,)-45-FLUORO-3,6-DIMETHYL-5-OXA-2,8-DIAZA-1(5,3)-PYRAZOLO(1,5-A)PYRIMIDINA-4(1,2)-BENZENANONAPHAN-9-ONE, (7S,13R)-11-Fluoro-7,13-Dimethyl-6,7,13,14-Tetrahydro-1,15-Ethenopyrazolo[4,3-F][1,4,8,10]Benzoxatriazacyclotridecin-4(5H)-OneCategories: MATE 2 Inhibitors, P-glycoprotein inhibitors
  10. Drug

    N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide

    go.drugbank.com/drugs/DB06940
    Experimental

    N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide is a solid. This compound belongs to the pyrrolotriazines. … N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide is known to target mitogen-activated protein kinase 14.

    Synonyms: N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide